dihydroethidium has been researched along with trypan blue in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (trypan blue) | Trials (trypan blue) | Recent Studies (post-2010) (trypan blue) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 2,857 | 40 | 414 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Han, J; Hong, Y; Ma, Y; Xia, W; Ying, W; Zhao, C | 1 |
1 other study(ies) available for dihydroethidium and trypan blue
| Article | Year |
|---|---|
NAD+ treatment decreases tumor cell survival by inducing oxidative stress.
Topics: Analysis of Variance; Astrocytes; Calcium; Cell Line, Tumor; Cell Survival; Ethidium; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Microscopy, Fluorescence; NAD; Oxidative Stress; Receptors, Purinergic P2X7; Trypan Blue | 2011 |